文献速递前列腺癌

病灶位置对非裔美国人前列腺癌MRI靶向穿刺检出率的影响

Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans.
PubMed 文献 · J Urol · 2019-01-01

该回顾性研究纳入125例男性的214个病灶,评估MRI靶向穿刺在前列腺外周带与移行带及不同种族间的检出效果。总体癌症检出率为50%,癌症升级率为41%,两者均不因前列腺带区或种族而显著不同;前部病灶检出率更高(p=0.0117)。

要点

  • MRI靶向穿刺对非裔与美国白人男性的检出效果相当。
  • 外周带与移行带病灶的癌症检出率(p=0.5468)和升级率(p=0.5134)无显著差异。
  • 前部病灶的癌症检出率显著更高(p=0.0117)。

核心结论

  • MRI靶向穿刺在非裔美国人与白人男性中效果相当,且不优先检出外周带或移行带的前列腺癌。

研究设计与样本

  • 单中心回顾性研究,纳入125例男性的214个病灶,由单一放射科组按PI-RADS v2判读。

主要发现

  • 214个病灶中162个(75.7%)位于外周带,52个(24.3%)位于移行带。
  • 非裔患者64个病灶,白人患者150个病灶,肿瘤位置分布成比例。
  • 48个前部病灶(22.4%)PI-RADS v2评分更高且趋势上尺寸更大。
  • 总体癌症检出率为50%,前列腺带区间(p=0.5468)与种族间(p=0.2294)无显著差异。
  • 癌症升级率为41%,前列腺带区间(p=0.5134)与种族间(p=0.2365)无显著差异。

临床怎么用

  • 对非裔美国男性行MRI靶向穿刺时,检出效能与白人男性相当,无需因种族调整穿刺策略。
  • 前部病灶检出率更高,应确保MRI靶向穿刺对前部病灶的充分采样。

局限性

  • 单中心回顾性设计,可能存在选择偏倚。
  • 样本量有限(125例男性,214个病灶)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The updated PI-RADS™ (Prostate Imaging Reporting and Data System) version 2 defines different grading parameters for lesions located in the peripheral zone vs the transition zone. It has contributed to the implementation of magnetic resonance imaging targeted biopsy. In this study we evaluated the efficacy of magnetic resonance imaging targeted biopsy among African American patients with additional consideration for lesion location on magnetic resonance imaging. MATERIALS AND METHODS: We performed a retrospective review of magnetic resonance imaging targeted biopsy at a single institution where a racially diverse population is treated. A single radiology group read the prostate multiparametric magnetic resonance imaging scans and followed PI-RADS version 2 algorithms to categorize lesions. RESULTS: A total of 214 lesions from 125 men were included in the analysis, of which 162 (75.7%) were in the peripheral zone and 52 (24.3%) were in the transition zone. There were 64 lesions from African American patients and 150 from Caucasian patients with tumor location distributed proportionately. The 48 anterior lesions (22.4%) had a higher PI-RADS version 2 score and trended toward a larger size. The overall cancer detection rate was 50%, which did not differ significantly between prostate zones (p = 0.5468) or racial groups (p = 0.2294). The cancer upgrade rate was 41% and it also did not differ significantly between prostate zones (p = 0.5134) or racial groups (p = 0.2365). Anterior lesions had a higher cancer detection rate (p = 0.0117) and trended toward a higher cancer upgrade rate (p = 0.0781). CONCLUSIONS: This study provides evidence that magnetic resonance imaging targeted biopsy is equally effective in African American and Caucasian men, and does not preferentially identify prostate cancer in the peripheral zone or the transition zone.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Walton E, Yaguchi G, Keeley J, et al. Effect of Lesion Location on Prostate Cancer Detection Rate with Magnetic Resonance Imaging Targeted Biopsy in African Americans. J Urol. 2019. PMID: 30316896. doi:10.1016/j.juro.2018.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。